{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-24-001235","form_type":"8-K","ticker":"JYNT","cik":"0001612630","company_name":"JOINT Corp","filed_at":"2024-03-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.807211+00:00","generated_at":"2026-06-05T01:34:33.457953+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"The Joint Corp. Reports Q4 2023 Revenue $30.6M, Full Year $117.7M, Net Loss $9.8M on Valuation Allowance","bullets":["Q4 2023 revenue grew 11% to $30.6M; system-wide sales up 11% to $133.1M","Full year 2023 revenue increased 16% to $117.7M; system-wide sales rose 12% to $488.0M","Reported net loss of $9.8M for 2023 including $10.8M non-cash valuation allowance; net income of $627K in 2022","Adjusted EBITDA for 2023 was $12.2M, up from $11.5M in 2022; clinic count grew to 935 from 838","Initiated refranchising program for majority of corporate clinics; 2024 guidance for system-wide sales $530M-$545M"],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-24-001235","json":"https://secwatch.observer/filing/0001171843-24-001235.json","markdown":"https://secwatch.observer/filing/0001171843-24-001235.md","text":"https://secwatch.observer/filing/0001171843-24-001235.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1612630/000117184324001235/0001171843-24-001235-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1612630/000117184324001235/f8k_030724.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T01:34:33.457953+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"26b487a5069b6ae6c38e1e33721729e703b62cc2","claim":"JOINT Corp reported financial results for the quarter and year ended December 31, 2023.","evidence_excerpt":"On March 7, 2024, The Joint Corp. (the \"Company\") issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1612630/000117184324001235/0001171843-24-001235-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter and year ended December 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}